Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 Studies on 2(1H)-quinolinone derivatives as gastric antiulcer active agents. 2-(4-Chlorobenzoylamino)-3-[2(1H)-quinolinon-4-yl]propi oni c acid and related compounds.

× No keyword cloud information.

8 in total

1. Intra-oral administration of rebamipide liquid prevents tongue injuries induced by X-ray irradiation in rats.

Authors: Takako Nakashima; Naoya Uematsu; Kazushi Sakurai
Journal: Support Care Cancer Date: 2017-02-15 Impact factor: 3.603

2. Effect of rebamipide, a novel antiulcer agent, on Helicobacter pylori adhesion to gastric epithelial cells.

Authors: S Hayashi; T Sugiyama; K Amano; H Isogai; E Isogai; M Aihara; M Kikuchi; M Asaka; K Yokota; K Oguma; N Fujii; Y Hirai
Journal: Antimicrob Agents Chemother Date: 1998-08 Impact factor: 5.191

3. Topical rebamipide improves the ocular surface in mild lagophthalmos.

Authors: Mariko Itakura; Hirotaka Itakura; Tomoyuki Kashima; Hideo Akiyama; Shoji Kishi
Journal: Clin Ophthalmol Date: 2013-07-01

4. Topical rebamipide improves lid wiper epitheliopathy.

Authors: Hirotaka Itakura; Tomoyuki Kashima; Mariko Itakura; Hideo Akiyama; Shoji Kishi
Journal: Clin Ophthalmol Date: 2013-10-31

5. Efficacy and safety of rebamipide liquid for chemoradiotherapy-induced oral mucositis in patients with head and neck cancer: a multicenter, randomized, double-blind, placebo-controlled, parallel-group phase II study.

Authors: T Yokota; T Ogawa; S Takahashi; K Okami; T Fujii; K Tanaka; S Iwae; I Ota; T Ueda; N Monden; K Matsuura; H Kojima; S Ueda; K Sasaki; Y Fujimoto; Y Hasegawa; T Beppu; H Nishimori; S Hirano; Y Naka; Y Matsushima; M Fujii; M Tahara
Journal: BMC Cancer Date: 2017-05-05 Impact factor: 4.430

Studies on 2(1H)-quinolinone derivatives as gastric antiulcer active agents. 2-(4-Chlorobenzoylamino)-3-[2(1H)-quinolinon-4-yl]propi oni c acid and related compounds.

1. Intra-oral administration of rebamipide liquid prevents tongue injuries induced by X-ray irradiation in rats.

2. Effect of rebamipide, a novel antiulcer agent, on Helicobacter pylori adhesion to gastric epithelial cells.

3. Topical rebamipide improves the ocular surface in mild lagophthalmos.

4. Topical rebamipide improves lid wiper epitheliopathy.

5. Efficacy and safety of rebamipide liquid for chemoradiotherapy-induced oral mucositis in patients with head and neck cancer: a multicenter, randomized, double-blind, placebo-controlled, parallel-group phase II study.

6. Resolution of persistent corneal erosion after administration of topical rebamipide.

Review 7. Rebamipide ophthalmic suspension for the treatment of dry eye syndrome: a critical appraisal.

8. Persistent corneal epithelial defect responding to rebamipide ophthalmic solution in a patient with diabetes.